CTLT  valuation analysis

Basics
Name: Catalent, Inc
Description: Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 02, 2021
Market cap: $19.33B (301st)
Sales(TTM): $3.46B (516th)
Earnings(TTM): $345.90M (415th)

Value
FFER: 2.05 (why)
Actual price: $113.64
FFEThis is Catalent, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $60.09
Quantile: CTLT is very expensive given its fundamentals.
Prices as of EOD 2021-03-02
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Catalent, Inc's earnings increased from -$126.40M to $345.90M in the last year.
Earnings / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry